Merck & Co Inc (NYSE: MRK) is -7.60% lower on its value in year-to-date trading and has touched a low of $98.60 and a high of $134.63 in the current 52-week trading range. The question becomes, what are the chances the stock will make a comeback and enjoy potential growth. Why not look at analysts view on what the future holds for the stock. The MRK stock was last observed hovering at around $102.92 in the last trading session, with the day’s loss setting it -2.19%.
Currently trading at $100.73, the stock is -3.87% and -8.74% below its SMA20 and SMA50 respectively. However, with a daily trading volume of 9.98 million and changing -2.13% at the moment leaves the stock -17.13% off its SMA200. MRK registered -1.61% loss for a year compared to 6-month loss of -22.09%. The firm has a 50-day simple moving average (SMA 50) of $110.7338 and a 200-day simple moving average (SMA200) of $121.64505.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
The stock witnessed a -8.20% gain in the last 1 month and extending the period to 3 months gives it a -11.94%, and is -1.12% down over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 1.96% over the week and 1.79% over the month.
Merck & Co Inc (MRK) has around 72000 employees, a market worth around $259.22B and $62.89B in sales. Current P/E ratio is 21.10 and Fwd P/E is 10.71. Profit margin for the company is 19.32%. Distance from 52-week low is 2.16% and -25.18% from its 52-week high. The company has generated returns on investments over the last 12 months (15.28%).
with sales reaching $15.5B over the same period.The EPS is expected to grow by 412.98% this year, but quarterly earnings will post 6.50% year-over-year. Quarterly sales are estimated to grow 5.90% in year-over-year returns.
Merck & Co Inc (MRK) Top Institutional Holders
4377.0 institutions hold shares in Merck & Co Inc (MRK), with institutional investors hold 79.72% of the company’s shares. The shares outstanding are 2.53B, and float is at 2.53B with Short Float at 1.03%. Institutions hold 79.67% of the Float.
The top institutional shareholder in the company is VANGUARD GROUP INC with over 244.68 million shares valued at $30.29 billion. The investor’s holdings represent 9.6596% of the MRK Shares outstanding. As of 2024-06-30, the second largest holder is BLACKROCK INC. with 207.3 million shares valued at $25.66 billion to account for 8.1838 of the shares outstanding. The other top investors are STATE STREET CORP which holds 117.49 million shares representing 4.6384% and valued at over $14.63 billion, while WELLINGTON MANAGEMENT GROUP LLP holds 2.8615 of the shares totaling 72.48 million with a market value of $8.97 billion.
Merck & Co Inc (MRK) Insider Activity
The most recent transaction is an insider purchase by Merck & Co., Inc., the company’s 10% Owner. SEC filings show that Merck & Co., Inc. bought 21,397,205 shares of the company’s common stock on Mar 11 ’24 at a price of $23.00 per share for a total of $492.14 million. Following the purchase, the insider now owns 1000.0 shares.
Merck & Co Inc disclosed in a document filed with the SEC on Feb 14 ’24 that Litchfield Caroline (EVP & CFO) sold a total of 38,291 shares of the company’s common stock. The trade occurred on Feb 14 ’24 and was made at $125.50 per share for $4.81 million. Following the transaction, the insider now directly holds 50908.0 shares of the MRK stock.
Still, SEC filings show that on Feb 13 ’24, Davis Robert M (Chairman, CEO & President) disposed off 150,000 shares at an average price of $125.85 for $18.88 million. The insider now directly holds 348,327 shares of Merck & Co Inc (MRK).
